市場調查報告書
商品編碼
1468012
獸用抗生素和抗菌藥物市場:按產品、交付方式、型態、動物類型 - 2024-2030 年全球預測Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年獸用抗生素市場規模為6.3551億美元,2024年將達6.6723億美元,2030年將達9.0984億美元,複合年成長率為5.25%。
獸用抗生素和抗菌藥物包括用於治療和預防細菌感染以及促進動物健康和福利的物質。由於飲食習慣的改變,全球對動物性蛋白質的需求不斷成長,推動了市場的發展。集約化畜牧業和人們對牲畜疾病預防重要性的認知不斷提高,導致抗生素使用量增加。此外,獸醫保健的進步以及對提高牲畜整體生產力的關注進一步推動了動物健康領域對抗生素和抗菌藥物的需求。對抗菌素抗藥性(AMR)的擔憂已成為一個主要問題,因為抗生素的過度使用會導致抗藥性細菌的產生。監管限制和採取更永續的農業實踐正在導致畜牧生產中某些抗生素的使用減少。傳統抗生素的抗生素替代品(例如益生菌和植物源)的發展趨勢不斷成長,為動物健康領域的創新提供了機會。此外,對疫苗和生物安全實踐等預防措施的日益關注為獸用抗生素和抗菌藥物市場的持續成長提供了機會。
主要市場統計 | |
---|---|
基準年[2023] | 63551萬美元 |
預測年份 [2024] | 66723萬美元 |
預測年份 [2030] | 9.0984億美元 |
複合年成長率(%) | 5.25% |
產品預防和治療疾病對抗生素的需求不斷增加
抗生素在動物保健中發揮重要作用,並用於多種目的,包括疾病預防、治療和促進生長。獸醫學中最常使用的抗生素是四環黴素、青黴素類、磺胺類藥物和大環內酯類。抗菌劑是一種破壞或抑制動物體內微生物生長的藥物。這些藥物包括抗生素、抗黴菌藥、抗原蟲藥和抗病毒藥物。其應用涵蓋酪農、家禽、養豬和水產養殖等多個領域,確保動物健康和福利,並減輕感染疾病的影響。
給藥方式:由於它是一種非侵入性操作,因此口服給藥的趨勢不斷增加。
注射是獸醫學中常用且有效的給藥方法,因為它是一種合理的給藥方法,並且可以直接吸收到血液中。這種給藥方法可繞過胃腸道,通常可以更快地起效。抗生素(例如青黴素和阿莫西林)和抗病毒藥物(例如磷酸奧司他韋)通常透過注射給藥,以實現有針對性的快速作用。口服獸用抗生素和抗菌劑是最非侵入性、最方便的給藥方法。其主要優點是易於管理,特別適合醫療技能最低的小規模農民和寵物飼主。
增加對嚴重型態感染疾病的動物使用抗菌解決方案
粉劑和錠劑是獸用抗生素和抗菌劑的常見固態形式。它因其最佳的穩定性、成本效益和精確的劑量而廣受歡迎。由於它是與飲用水或飼料混合口服給藥,因此在獸醫診所使用很方便。抗菌液通常透過相關途徑輸送,例如口服、乳房內和腸胃外給藥。它可以治療多種細菌感染疾病,並提供即時作用和快速吸收。此溶液的劑量可以輕鬆修改,從而可以根據不同動物的需求輕鬆制定個人化的治療計劃。
動物類型伴同性動物對抗生素和抗菌藥物來控制細菌感染疾病的需求正在成長
包括貓在內的伴同性動物容易受到多種細菌感染疾病,其表現形式多種多樣,包括尿道感染和貓抓病。阿莫西林和多西環素等抗生素因其廣譜抗菌特性而被廣泛使用。獸醫經常開抗生素治療狗的細菌感染,例如恩諾沙星或阿莫西林。治療的常見疾病包括皮膚感染疾病、尿道感染和呼吸道疾病。馬科醫學常用的抗生素包括青黴素、慶大霉素和四環黴素,用於治療肺炎、皮膚感染疾病和再生性貧血等疾病。施用正確的劑量對於防止微生物抗藥性至關重要。抗生素對於牛健康管理至關重要。四環黴素和磺胺類藥物抗生素通常用於預防牛的呼吸道疾病和乳房炎。濫用抗生素會導致抗菌素抗藥性和食物鏈污染。生豬生產中常使用抗生素,包括林可黴素和四環黴素,以預防豬痢疾和肺炎等疾病。保持負責任地使用抗生素對於確保食品安全至關重要。恩諾沙星、阿莫西林和多西環素常用於家禽養殖,用於治療和預防禽霍亂、傳染性支氣管炎和球蟲等疾病。
區域洞察
在美洲,集中畜牧業和對動物福利的日益重視正在推動獸用抗生素和抗菌藥物市場的發展。對動物產品的需求不斷增加,人們對牲畜疾病預防的認知不斷提高,促進了抗生素在該地區的普及。先進的獸醫醫療基礎設施和嚴格的法規進一步塑造了這一格局,北美和南美國家積極為市場格局的擴大做出貢獻。在亞太地區,由於對動物性蛋白質的需求不斷增加,獸用抗生素和抗菌藥物市場正在經歷顯著成長,特別是在中國和印度等國家。畜牧業的擴張以及對改善動物健康和生產力的日益關注正在推動抗生素在該地區的應用。在歐洲、中東和非洲地區,有關牲畜使用抗生素的嚴格規定正在影響獸用抗生素市場,特別是在歐洲國家。對永續農業實踐的重視以及對抗菌素抗藥性日益成長的擔憂也有助於塑造市場動態。此外,由於都市化程度的提高和飲食習慣的改變,中東和非洲的畜牧業活動正在擴大。歐洲、中東和非洲地區在引導世界負責任、有效使用獸用抗生素和抗菌藥物方面發揮著至關重要的作用。
FPNV定位矩陣
FPNV定位矩陣對於評估獸用抗生素和抗菌藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對獸用抗生素和抗生素市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.獸用抗生素/抗菌藥市場規模及預測如何?
2.在獸用抗生素和抗生素市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.獸用抗生素/抗菌藥市場的技術趨勢和法規結構是什麼?
4.獸用抗生素/抗生素市場主要供應商的市場佔有率是多少?
5. 進入獸用抗生素/抗菌藥物市場的適當型態和策略性手段是什麼?
[190 Pages Report] The Animal Antibiotics & Antimicrobials Market size was estimated at USD 635.51 million in 2023 and expected to reach USD 667.23 million in 2024, at a CAGR 5.25% to reach USD 909.84 million by 2030.
Animal antibiotics & antimicrobials include substances used to treat and prevent bacterial infections in animals, promoting their health and welfare. The rising global demand for animal protein, driven by changing dietary patterns, is driving the market. The intensification of animal farming and increased awareness of the importance of preventing diseases in livestock contribute to the growing usage of antibiotics. Additionally, advancements in veterinary healthcare and a focus on improving overall animal productivity further propel the demand for antibiotics & antimicrobials in the animal health sector. Concerns over antimicrobial resistance (AMR) pose a significant challenge, as the overuse of antibiotics can lead to the development of resistant strains of bacteria. Regulatory restrictions and a push towards more sustainable farming practices contribute to the restraint on the use of certain antibiotics in animal agriculture. The growing trend toward the development of alternatives to traditional antibiotics, such as probiotics and phytogenics, presents an opportunity for innovation in the animal health sector. Furthermore, increased focus on preventive measures, such as vaccines and biosecurity practices, offers opportunities for sustainable growth in the animal antibiotics & antimicrobials market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 635.51 million |
Estimated Year [2024] | USD 667.23 million |
Forecast Year [2030] | USD 909.84 million |
CAGR (%) | 5.25% |
Product: Growing need for antibiotics for disease prevention and treatment
Antibiotics present a significant component in animal healthcare, deployed for a myriad of purposes, including disease prevention, treatment, and growth promotion. The most commonly used antibiotics in the animal health sector are tetracyclines, penicillins, sulfonamides, and macrolides. Antimicrobials are agents that destroy or inhibit the growth of microorganisms in animals. These include antibiotics, antifungals, antiprotozoals, and antivirals. Their application spans various segments, including dairy, poultry, swine, and aquaculture, to ensure the health and welfare of animals and to mitigate the impacts of infectious diseases.
Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
Injection is a common and effective method of drug delivery in veterinary medicine due to its streamlined administration and direct absorption into the bloodstream. This mode of delivery bypasses the digestive barriers and often results in a faster onset of medical action. Antibiotics such as penicillin, amoxicillin, and antivirals such as oseltamivir phosphate are often administered via injections for targeted, immediate relief. Oral delivery of antibiotics & antimicrobials for animals is the most non-invasive and convenient mode of delivery. Its main advantage lies in its ease of administration, particularly suitable for small scale farmers or pet owners with minimal medical proficiency.
Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
Powders & tablets are common solid dosage forms for animal antibiotics and antimicrobials. They have gained traction due to their optimal stability, cost-effectiveness, and the potential for precision dosing. They are administered orally in drinking water or feed, making them a convenient option for veterinary use. Antimicrobial solutions are typically provided through allied routes, including oral, intramammary, or parenteral administration. They cater to a broad spectrum of bacterial infections and provide instant relief and rapid absorption. Solutions can be easily modified in terms of dosage, facilitating personalized treatment plans based on varying animal needs.
Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
Companion animals including cats are prone to various bacterial infections, which manifest in different forms of diseases such as urinary tract infection and cat-scratch disease. Antibiotics such as amoxicillin and doxycycline are commonly used for their broad-spectrum antimicrobial properties. Veterinarians often prescribe antibiotics including enrofloxacin and amoxicillin for bacterial infections in dogs. Some common illnesses treated include skin infections, urinary tract infections, and respiratory diseases. Common antibiotics used in equine medicine include penicillin, gentamicin, and oxytetracycline to treat ailments such as pneumonia, skin infections, and regenerative anemia. It's crucial to administer the correct dosage to prevent microbial resistance. Antibiotics are vital for cattle health management. Tetracyclines and sulfonamides are frequently used for the prevention of bovine respiratory disease and mastitis. Misuse of antibiotics can lead to antimicrobial resistance and food-chain contamination. Frequent use of antibiotics in swine production, including lincomycin and chlortetracycline, is common for the prevention of diseases such as swine dysentery and pneumonia. It's essential to maintain the responsible use of antibiotics to ensure food safety. Enrofloxacin, amoxicillin, and doxycycline are typically used in poultry farming for the treatment and prevention of diseases such as avian cholera, infectious bronchitis and coccidiosis.
Regional Insights
In the Americas, the market for animal antibiotics & antimicrobials is driven by the significant presence of intensive animal farming practices and a growing emphasis on animal welfare. The rising demand for animal-derived products, coupled with increased awareness of disease prevention in livestock, contributes to the widespread use of antibiotics in the region. Advanced veterinary healthcare infrastructure and stringent regulations further shape the landscape, with North and South American countries actively contributing to the expansion of the animal antibiotics & antimicrobials market. In the Asia-Pacific region, the animal antibiotics & antimicrobials market experiences substantial growth due to the increasing demand for animal protein, particularly in countries including China and India. The expansion of the livestock industry, coupled with a rising focus on improving animal health and productivity, drives the adoption of antibiotics in the region. Within the EMEA region, the market for animal antibiotics & antimicrobials is influenced by stringent regulations on antibiotic use in livestock, particularly in European countries. The emphasis on sustainable farming practices and heightened concerns about antimicrobial resistance contribute to shaping the market dynamics. Additionally, the Middle East and Africa witness growth in animal farming activities, driven by increasing urbanization and dietary changes. The EMEA region plays a pivotal role in steering the global direction of responsible and effective use of animal antibiotics & antimicrobials.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibiotics & Antimicrobials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibiotics & Antimicrobials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Animal Antibiotics & Antimicrobials Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibiotics & Antimicrobials Market?
3. What are the technology trends and regulatory frameworks in the Animal Antibiotics & Antimicrobials Market?
4. What is the market share of the leading vendors in the Animal Antibiotics & Antimicrobials Market?
5. Which modes and strategic moves are suitable for entering the Animal Antibiotics & Antimicrobials Market?